findmyKOL
Clinical trialNCT01768468CompletedPhase 4Interventional

To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients

SponsorPMG Pharm Co., LtdEnrollment124Osteoarthritis of the Knee
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Keimyug University Dongsan Medical Center

    Daegu, South Korea

  • Hanyang University Guri Hospital

    Seoul, South Korea

  • Korea University Anam Hospital

    Seoul, South Korea

  • Smg-Snu Boramae Medical Center

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Ajou University Hospital

    Suwon, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2012
Primary completion
30 Jun 2013
Completion
30 Sept 2013
Last update posted
14 Oct 2013
Registered enrollment
124
Registry id
NCT01768468

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.